These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1146026)

  • 21. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of delagil on the blood coagulation system and the interrelation with heparin].
    Ovchinnikova LK; Pomortseva IV
    Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of various doses and various applications of heparin on the fat metabolism and on blood coagulation.
    Losonczy H; Nagy I
    Wien Klin Wochenschr; 1984 Dec; 96(24):885-9. PubMed ID: 6528619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cortical bone and serum concentrations of clindamycin achievable by direct local infusion and intravenous administration.
    Budsberg SC; Gallo JM; Starliper CE; Shotts EB; Brown J
    J Orthop Res; 1991 Jul; 9(4):594-9. PubMed ID: 2045986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How much heparin do we really need to go on pump? A rethink of current practices.
    Shuhaibar MN; Hargrove M; Millat MH; O'Donnell A; Aherne T
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):947-50. PubMed ID: 15519187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A portable insulin infusion system with a rotary solenoid-driven peristaltic pump.
    Carlson GA; Love JT; Urenda RS; Spencer WJ; Eaton RP
    Med Prog Technol; 1980; 8(1):49-56. PubMed ID: 7007857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of heparin in the early post-traumatic period in burns and hemorrhage].
    Kil'diushov AN
    Anesteziol Reanimatol; 1994; (5):26-8. PubMed ID: 7893070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous long term heparin therapy--dosage problems using an Infusaid device.
    Späth G; Helber MU; Eisele R
    Life Support Syst; 1985; 3(1):57-9. PubMed ID: 3990349
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial.
    Garachemani AR; Kaufmann U; Fleisch M; Meier B
    Am Heart J; 1998 Aug; 136(2):352-6. PubMed ID: 9704701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial].
    Benahmed M; Carde P; Laplanche A; Renaux J; Rouesse J; Spielmann M; Sancho-Garnier H
    Bull Cancer; 1985; 72(1):30-6. PubMed ID: 2580579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [-Value of activated blood coagulation time in monitoring anticoagulation during coronary angioplasty-].
    Kunert M; Sorgenicht R; Scheuble L; Ketteler T; Lürken E; Meyer I; Müller A; Emmerich K; Gülker H
    Z Kardiol; 1996 Feb; 85(2):118-24. PubMed ID: 8650981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin versus citrate regional anticoagulation during autotransfusion in a porcine intra-abdominal hemorrhage model.
    Howdieshell TR; Gay M; DiPiro JT; Mooney S; Duvall R; Eckles S; Baisden R
    Am Surg; 1997 Nov; 63(11):1014-8. PubMed ID: 9358794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
    Klenner AF; Fusch C; Rakow A; Kadow I; Beyersdorff E; Eichler P; Wander K; Lietz T; Greinacher A
    J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One year of heparin anticoagulation. An ambulatory subject using a totally implantable infusion pump.
    Rohde TD; Blackshear PJ; Varco RL; Buchwald H
    Minn Med; 1977 Oct; 60(10):719-22. PubMed ID: 909524
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.